148 related articles for article (PubMed ID: 32333005)
21. Adaptive immune response to therapy in hmgcr autoantibody myopathy.
Yi JS; Russo MA; Weinhold KJ; Guptill JT
Muscle Nerve; 2016 Feb; 53(2):313-7. PubMed ID: 26492512
[TBL] [Abstract][Full Text] [Related]
22. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child.
Mohassel P; Foley AR; Donkervoort S; Fequiere PR; Pak K; Bönnemann CG; Mammen AL
Muscle Nerve; 2017 Dec; 56(6):1177-1181. PubMed ID: 28066895
[TBL] [Abstract][Full Text] [Related]
23. Immune-mediated necrotizing myopathy due to statins exposure.
Villa L; Lerario A; Calloni S; Peverelli L; Matinato C; DE Liso F; Ceriotti F; Tironi R; Sciacco M; Moggio M; Triulzi F; Cinnante C
Acta Myol; 2018 Dec; 37(4):257-262. PubMed ID: 30944904
[TBL] [Abstract][Full Text] [Related]
24. Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort.
Waters MJ; Limaye V
Clin Rheumatol; 2018 Feb; 37(2):543-547. PubMed ID: 28905130
[TBL] [Abstract][Full Text] [Related]
25. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
[TBL] [Abstract][Full Text] [Related]
26. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M
Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
[TBL] [Abstract][Full Text] [Related]
27. Commentary.
Mammen A
Clin Chem; 2015 Sep; 61(9):1136. PubMed ID: 26319450
[No Abstract] [Full Text] [Related]
28. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.
Jones B
Ann Clin Biochem; 2014 Jul; 51(4):516. PubMed ID: 28071082
[No Abstract] [Full Text] [Related]
29. Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive myopathy associated with advanced stage of cutaneous squamous cell carcinoma.
Kusutani N; Yamanaka-Takaichi M; Yanagishita-Nakatsuji S; Kadoya M; Hasegawa I; Tsutada T; Shimizu J; Ohe S; Isei T; Itoh Y; Fukai K; Tateishi C; Tsuruta D
Australas J Dermatol; 2021 Aug; 62(3):e460-e462. PubMed ID: 34028804
[No Abstract] [Full Text] [Related]
30. Anti-HMGCR antibody-associated necrotizing myopathy: diagnosis and treatment illustrated using a case report.
Giudizi MG; Cammelli D; Vivarelli E; Biagiotti R; Ferraro A; Bentow C; Almerigogna F; Albesa R; Mahler M
Scand J Rheumatol; 2016 Oct; 45(5):427-9. PubMed ID: 26886059
[No Abstract] [Full Text] [Related]
31. [Screening of autoantibodies associated with necrotizing myopathy among undiagnosed chronic myopathy].
Kuru S; Suzuki S; Ogata K; Kobayashi M; Ishida C; Watanabe C; Matsumura T
Rinsho Shinkeigaku; 2017 Oct; 57(10):562-566. PubMed ID: 28954975
[TBL] [Abstract][Full Text] [Related]
32. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.
Allenbach Y; Drouot L; Rigolet A; Charuel JL; Jouen F; Romero NB; Maisonobe T; Dubourg O; Behin A; Laforet P; Stojkovic T; Eymard B; Costedoat-Chalumeau N; Campana-Salort E; Tournadre A; Musset L; Bader-Meunier B; Kone-Paut I; Sibilia J; Servais L; Fain O; Larroche C; Diot E; Terrier B; De Paz R; Dossier A; Menard D; Morati C; Roux M; Ferrer X; Martinet J; Besnard S; Bellance R; Cacoub P; Arnaud L; Grosbois B; Herson S; Boyer O; Benveniste O;
Medicine (Baltimore); 2014 May; 93(3):150-157. PubMed ID: 24797170
[TBL] [Abstract][Full Text] [Related]
33. Anti-HMGCR Antibody-Related Necrotizing Autoimmune Myopathy Mimicking Muscular Dystrophy.
Tard C; Tiffreau V; Jaillette E; Jouen F; Nelson I; Bonne G; Yaou RB; Romero N; Vallée L; Vermersch P; Nguyen S; Maurage CA; Cuisset JM
Neuropediatrics; 2017 Dec; 48(6):473-476. PubMed ID: 28778101
[No Abstract] [Full Text] [Related]
34. Anti-HMGCR autoantibodies in self-limiting statin-induced myopathy.
Keating P; Young J; George P; Florkowski C; Spellerberg M; Kennedy N
Int J Rheum Dis; 2017 Dec; 20(12):2179-2181. PubMed ID: 28185416
[No Abstract] [Full Text] [Related]
35. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.
Allenbach Y; Keraen J; Bouvier AM; Jooste V; Champtiaux N; Hervier B; Schoindre Y; Rigolet A; Gilardin L; Musset L; Charuel JL; Boyer O; Jouen F; Drouot L; Martinet J; Stojkovic T; Eymard B; Laforêt P; Behin A; Salort-Campana E; Fain O; Meyer A; Schleinitz N; Mariampillai K; Grados A; Benveniste O
Brain; 2016 Aug; 139(Pt 8):2131-5. PubMed ID: 27086869
[TBL] [Abstract][Full Text] [Related]
36. Anti-HMGCR Myopathy.
Mohassel P; Mammen AL
J Neuromuscul Dis; 2018; 5(1):11-20. PubMed ID: 29480216
[TBL] [Abstract][Full Text] [Related]
37. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.
Liang WC; Uruha A; Suzuki S; Murakami N; Takeshita E; Chen WZ; Jong YJ; Endo Y; Komaki H; Fujii T; Kawano Y; Mori-Yoshimura M; Oya Y; Xi J; Zhu W; Zhao C; Watanabe Y; Ikemoto K; Nishikawa A; Hamanaka K; Mitsuhashi S; Suzuki N; Nishino I
Rheumatology (Oxford); 2017 Feb; 56(2):287-293. PubMed ID: 27818386
[TBL] [Abstract][Full Text] [Related]
38. Identical twins with statin-associated anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibody-positive autoimmune myopathy.
Mali M; Pirilä L; Perander L; Gardberg M; Jokela M
Scand J Rheumatol; 2024 Jan; 53(1):81-82. PubMed ID: 38090763
[No Abstract] [Full Text] [Related]
39. Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies.
Musset L; Miyara M; Benveniste O; Charuel JL; Shikhman A; Boyer O; Fowler R; Mammen A; Phillips J; Mahler M
J Immunol Res; 2014; 2014():405956. PubMed ID: 24741598
[TBL] [Abstract][Full Text] [Related]
40. Statins and myositis: the role of anti-HMGCR antibodies.
Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I
Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
